Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,544 JPY | -2.83% | -3.56% | -11.21% |
2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.21% | 248M | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- 4554 Stock
- News Fuji Pharma Co., Ltd.
- Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan